Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | JNJ-26483327 |
Trade Name | |
Synonyms | BGB-102 |
Drug Descriptions |
JNJ-26483327 (BGB-102) is a multi-kinase inhbitor, which inhibits wild-type and mutant EGFR, RET, and has activity against VEGFR3, ERBB2 (HER2), ERBB4, and SRC family members (PMID: 20823884). |
DrugClasses | EGFR Inhibitor (Pan) 61 HER2 Inhibitor 41 RET Inhibitor 52 |
CAS Registry Number | 807640-87-5 |
NCIT ID | C77866 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-26483327 | JNJ-26483327 | 0 | 0 |